FDA Clears Insulin Pump Therapy Device

The FDA has approved the Accu-Chek Combo system, a combination blood glucose meter and insulin pump that exchanges data using Bluetooth technology.

Manufactured by Roche Diagnostics in Indianapolis, the Accu-Chek system uses a full-color display for blood glucose data, insulin dose information and pump settings, allowing users to remotely calculate and administer a bolus accordingly. Bluetooth technology allows for wireless communication between the insulin pump and user data.

“This new system is designed to support insulin pump patients in managing diabetes easily and discreetly in their everyday life,” said Luc Vierstraete, head of Roche Diabetes Care.

The device has been launched in several countries in Europe and the Asian-Pacific, according to a press release issued by the company.

Loading links....
You must be a registered member of Renal and Urology News to post a comment.